Prognostic Value of Immunoscore and PD-L1 Expression in Metastatic Colorectal Cancer Patients with Different RAS Status after Palliative Operation

Colorectal cancer (CRC) is the fifth leading cause of cancer death and the fifth most commonly diagnosed cancer in China. Approximately, 25% of CRC was in the advanced stage as diagnosed, and 40% of patients with CRC progress to metastatic colorectal cancer (mCRC). RAS mutation status is now routine...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Biomed Res Int
Главные авторы: Liu, Ruiqi, Peng, Ke, Yu, Yiyi, Liang, Li, Xu, Xiaojing, Li, Wei, Yu, Shan, Liu, Tianshu
Формат: Artigo
Язык:Inglês
Опубликовано: Hindawi 2018
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5831827/
https://ncbi.nlm.nih.gov/pubmed/29662888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/5920608
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы